UBS Group’s iPath Pure Beta Softs ETN GRWN Stock Holding History

UBS Group’s Portfolio GRWN Stock Details GRWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-87	Closed	-$2K	–	8284
2016 Q3	$2K	Hold	87	–	–	﹤0.01%	7462
2016 Q2	$2K	Sell	87 -137	-61%	-$3.38K	﹤0.01%	7494
2016 Q1	$5K	Buy	224 +91	+68%	+$1.86K	﹤0.01%	7037
2015 Q4	$3K	Sell	133 -91	-41%	-$1.93K	﹤0.01%	7938
2015 Q3	$4K	Buy	224 +95	+74%	+$1.84K	﹤0.01%	7877
2015 Q2	$3K	Buy	129 +15	+13%	+$326	﹤0.01%	8120
2015 Q1	$2K	Buy	114 +42	+58%	+$1.05K	﹤0.01%	8496
2014 Q4	$2K	Buy	+72	New	+$2.1K	﹤0.01%	9468

UBS Group's GRWN Position: Q4 2016 in Review

UBS Group sold out of iPath Pure Beta Softs ETN (GRWN) in Q4 2016, closing a stake of 87 shares — an estimated $2K sold.

UBS Group first reported a position in GRWN in Q4 2014 and held it in 8 quarters. The position peaked at $5K in Q1 2016. 0 funds tracked by Wall St. Rank hold GRWN as of Q4 2016.

UBS Group reported no remaining iPath Pure Beta Softs ETN position as of Q4 2016 after selling out during the quarter.
UBS Group sold 87 iPath Pure Beta Softs ETN shares in Q4 2016, an estimated $2K.
UBS Group first reported a position in iPath Pure Beta Softs ETN in Q4 2014 and held it in 8 quarters.
UBS Group's iPath Pure Beta Softs ETN position peaked at $5K in Q1 2016.
0 funds tracked by Wall St. Rank held iPath Pure Beta Softs ETN as of Q4 2016.

Based on UBS Group's 13F filing for Q4 2016, filed 14 Feb 2017.